Geneva, May 4 -- International Clinical Trials Registry received information related to the study (CTRI/2026/04/108985) titled 'A study on adjusting Fluoxetine dose with a beneficial gut bacteria to improve treatment in people with depression' on April 21.
Study Type: Interventional
Study Design:
Randomized, Parallel Group, Placebo Controlled Trial Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Case Record Numbers Blinding and masking:Participant Blinded
Primary Sponsor: JSS COLLEGE OF PHARMACY
Condition:
Health Condition 1: F688- Other specified disorders of adultpersonality and behavior
Intervention:
Intervention1: SSRI AND PROBIOTIC: FLUOXETINE 20MG once daily e...